— Calyxt Announces 1-for-5 Reverse Stock Split of Common Stock — ROSEVILLE, Minn., May 19, 2023 /PRNewswire/ — Calyxt, Inc. (Nasdaq: CLXT) (“Calyxt” or the “Company”) today announced the results of the special meeting of its stockholders held on May 18, 2023. At the special meeting, Calyxt’s stockholders voted in favor of all proposals, including … Read more
SILVER SPRING, Md., May 19, 2023 /PRNewswire/ — Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: Today, the FDA announced that the National Academies of Sciences, Engineering, and Medicine (NASEM) will conduct an independent study on challenges in supply, market competition, and regulation of infant … Read more
Agency Continues to Support Innovation of Next-Generation Technology in Diabetes Management SILVER SPRING, Md., May 19, 2023 /PRNewswire/ — Today, the U.S. Food and Drug Administration cleared the Beta Bionics iLet ACE Pump and the iLet Dosing Decision Software for people six years of age and older with type 1 diabetes. These two devices, along with … Read more
SILVER SPRING, Md., May 19, 2023 /PRNewswire/ — Today, the U.S. Food and Drug Administration approved Vyjuvek, a herpes-simplex virus type 1 (HSV-1) vector-based gene therapy, for the treatment of wounds in patients 6 months of age and older with dystrophic epidermolysis bullosa (DEB) with mutation(s) in the collagen type VII alpha 1 chain (COL7A1) gene. … Read more
By Laura Powell, Managing Consultant and Eric Jia-Sobota, Founder CHARLESTON, S.C. , May 19, 2023 /PRNewswire/ — In the latest amendment to its Broad Agency Announcement (BAA), BARDA (Biomedical Advanced Research and Development Authority) is seeking proposals for the development of cost-effective and adaptable therapeutic platforms to treat viral infections, as well as next-generation COVID-19 vaccines. … Read more
Ticker symbol change effective at the market open May 22, 2023 NEW YORK, May 19, 2023 /PRNewswire/ — Fresh2 Group Ltd., formerly AnPac Bio-Medical Science Co., Ltd. (NASDAQ: ANPC), a company with operations in the United States and China focused on early cancer screening and detection and plans to enter into the operation of a business-to-business e-commerce food platform focused on … Read more
CHICAGO, May 19, 2023 /PRNewswire/ — The cell isolation industry is poised for significant advancements in the near future. With the rapid progress in biotechnology and regenerative medicine, there is a growing need for precise and efficient methods of isolating specific cell populations. Cell isolation techniques enable researchers and clinicians to obtain pure and viable … Read more
Caron continues its global expansion in the Life Science market MARIETTA, Ohio , May 19, 2023 /PRNewswire/ — Today, Caron Products and Services, Inc. (“Caron”), a leading provider of laboratory equipment used in small and large molecule drug development and manufacturing, cell, and gene therapy research, and academic research, announced that Sebastian Scott has joined Caron’s Leadership Team … Read more
SAN DIEGO, May 19, 2023 /PRNewswire/ — Kintara Therapeutics, Inc. (Nasdaq: KTRA) (“Kintara” or the “Company”), a biopharmaceutical company focused on the development of new solid tumor cancer therapies, today announced its participation in the Nasdaq Closing Bell Ceremony on May 19, 2023. The event will serve as a commemoration of National Brain Tumor Awareness Month … Read more
EMERYVILLE, Calif., May 19, 2023 Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world’s transition to sustainable consumption through its Lab-to-Market™ technology platform and clean beauty consumer brands, today announced that it has signed an exclusive license agreement with British specialty chemicals company Croda International Plc, (“Croda”) for the supply of sustainable squalene. … Read more